The National Institute for Occupational Safety and Health (NIOSH)
Organic Solvent Neurotoxicity
DHHS (NIOSH) Publication Number 87-104
March 1987
Current Intelligence Bulletin 48
Foreword
Current Intelligence Bulletins (CIB's) are issued by the National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control, Atlanta, Georgia, for the purpose of disseminating new scientific information about occupational hazards. A CIB may draw attention to a previously unrecognized hazard, or it may report new data suggesting that a known hazard is either more or less dangerous than was previously thought.
CIB's are prepared by the staff of the Division of Standards Development and Technology Transfer, NIOSH (Robert A. Taft Laboratories, 4676 Columbia Parkway, Cincinnati, Ohio 45226). They are distributed to representatives of academia, industry, organized labor, public health agencies, and public interest groups as well as to those Federal agencies that have responsibilities for protecting the health of workers. Our intention is to provide anyone who needs it with ready access to the information in these documents; we welcome suggestions concerning their content, style, and distribution.
Many organic solvents are recognized by NIOSH as carcinogens or reproductive hazards in the workplace. Examples of carcinogens recognized by NIOSH are benzene, carbon tetrachloride, trichloroethylene, and 1,1,2,2-tetrachloroethane. Reproductive hazards recognized by NIOSH include 2- methoxyethanol, 2-ethoxyethanol, and methyl chloride. This CIB describes other research results indicating the potential for organic solvents and various mixtures of organic solvents to cause neurotoxic effects in workers exposed to these substances. Neurotoxic disorders are listed by NIOSH among the ten leading work-related diseases and injuries. Because of expected increases in the manufacture of organic solvents, many of which may be neurotoxic, the population of exposed workers is likely to increase. NIOSH estimates that 9.8 million workers are potentially exposed to organic solvents used in such products as paints, adhesives, glues, coatings, and degreasing/cleaning agents, and in the production of dyes, polymers, plastics, textiles, printing inks, agricultural products, and pharmaceuticals.
No precise determination has been made of the excess risk of neurotoxic effects in workers exposed to specific concentrations of organic solvents, but the probability of developing such effects would be decreased by reducing exposure. NIOSH therefore recommends (1) that producers and users of organic solvents disseminate this information to their workers and customers, (2) that professional and trade associations and unions inform their members of the potential neurotoxic effects of working with organic solvents, and (3) that appropriate engineering controls, personal protective equipment, and worker education programs be used to reduce worker exposures--at least to the concentrations specified in existing Occupational Safety and Health Administration (OSHA) permissible exposure limits (PEL's), or to NIOSH recommended exposure limits (REL's) or the American Conference of Governmental Industrial Hygienists (ACGIH) threshold values (TLVs®) if they provide a greater degree of protection.
[signature]
J. Donald Millar, M.D., D.T.P.H. (Lond.)
Assistant Surgeon General
Director, National Institute for
Occupational Safety and Health
Centers for Disease Control
J. Donald Millar, M.D., D.T.P.H. (Lond.)
Assistant Surgeon General
Director, National Institute for
Occupational Safety and Health
Centers for Disease Control
Abstract
The acute neurotoxic effects of organic solvent exposure in workers and laboratory animals are narcosis, anesthesia, central nervous system (CNS) depression, respiratory arrest, unconsciousness, and death. Acute experimental exposures of human volunteers to one or several organic solvents have impaired psychomotor function as measured by reaction time, manual dexterity, coordination, or body balance. Chronic animal studies with a limited number of organic solvents support the evidence for peripheral neuropathy and mild toxic encephalopathy in solvent-exposed workers. Epidemiologic studies of various groups of solvent-exposed workers have demonstrated statistically significant chronic changes in peripheral nerve function (sensory and motor nerve conduction velocities and electromyographic abnormalities) that persisted for months to years following cessation of exposure. Epidemiologic studies have also shown statistically significant increases in neurobehavioral effects in workers chronically exposed to organic solvents. These effects include disorders is characterized by reversible subjective symptoms (fatigability, irritability, and memory impairment), sustained changes in personality or mood (emotional instability and diminished impulse control and motivation), and impaired intellectual function (decreased concentration ability, memory, and learning ability). Among organic solvent abusers, the most severe disorders reported are characterized by irreversible deterioration in intellect and memory (dementia) accompanied by structural CNS damage.
On the basis of the identified adverse health effects of solvent exposure, the National Institute for Occupational Safety and Health (NIOSH) recommends that employers use engineering controls, personal protective equipment and clothing, and worker education programs to reduce exposure to organic solvents--at least to the concentrations specified in existing Occupational Safety and Health Administration (OSHA) permissible exposure limits (PEL's), or to NIOSH recommended exposure limits (REL's) or the American Conference of Governmental Industrial Hygienists (ACGIH) threshold limit values (TLVs®) if they provide a greater degree of protection.
Background
Physical and Chemical Properties
The term "organic solvents" refers to a group of volatile compounds or mixtures that are relatively stable chemically and that exist in the liquid state at temperatures of approximately 0° to 250°C (32° to 482°F). Common organic solvents are classified as aliphatic hydrocarbons, cyclic hydrocarbons, aromatic hydrocarbons, halogenated hydrocarbons, ketones, amines, esters, alcohols, aldehydes, and ethers. Many common solvents often exist as mixtures or blends of chemical compounds (e.g., Stoddard solvent and thinners) (WHO 1985; Parrish 1983).
Production, Use, and Potential for Occupational Exposure
Organic solvents are used for extracting, dissolving, or suspending materials such as fats, waxes, and resins that are not soluble in water. The removal of the solvent from a solution permits the recovery of the solute intact with its original properties (Considine 1976). Solvents are used in paints, adhesives, glues, coatings, and degreasing/cleaning agents, and in the production of dyes, polymers, plastics, textiles, printing inks, agricultural products, and pharmaceuticals (WHO 1985;Parrish 1983). In 1984, approximately 49 million tons of industrial solvents were produced in the United States (USITC 1985).
Approximately 9.8 million workers are potentially exposed to organic solvents. This estimate is based on data collected during the National Occupational Hazard Survey conducted by the National Institute for Occupational Safety and Health (NIOSH) during 1972-1974 (NIOSH 1977d).
Exposure Limits
The Occupational Safety and Health Administration (OSHA) has promulgated permissible exposure limits (PEL's) for occupational exposure to some of the chemicals and mixtures that are used as organic solvents (29 CFR* 1910.1000). Each PEL is determined as an 8-hr time-weighted average (TWA) concentration, and it is based on the 1968 threshold limit value TLV of the American Conference of Governmental Industrial Hygienists (ACGIH) (ACGIH 1968) for a specific organic solvent.
NIOSH has established recommended exposure limits (REL's) for 92 chemicals and mixtures that can be defined as organic solvents. Appendix A lists those chemicals and mixtures with NIOSH REL's, OSHA PEL's, and ACGIH TLVs (ACGIH 1986). Additional organic solvent PEL's and TLVs are listed in 29 CFR 1910.1000 and in TLVs® Threshold Limit Values and Biological Exposure Indices for 1986-1987 (ACGIH 1986), respectively.
Toxicity
Results of Animal Studies
Acute Toxicity
To date, most experimental animal studies with organic solvents have been conducted to determine their acute neurotoxic effects on the central nervous system (CNS) rather than the potential chronic neurotoxic effects from long-term exposure. The acute toxic effects of solvent inhalation noted in animals reflect those seen in humans--that is, narcosis, anesthesia, CNS depression, respiratory arrest, unconsciousness, and death (Browning 1965).
Chronic Toxicity
Experimental and neuropathologic animal studies support the evidence associating a limited number of organic solvents (Appendix B) with the peripheral neuropathy and mild toxic encephalopathy observed in exposed humans. However, the majority of solvents in daily use have yet to be tested for chronic neurotoxic effects in animals, and therefore an adequate animal model for the induction of these effects is not yet available. An animal model of the mechanism of pathogenesis would lead to more accurate methods for predicting the neurotoxicity of organic solvents. In research studies to develop animal models for neurotoxicity (Haglid et al. 1981, 1985), Mongolian gerbils were exposed to one of four organic solvents (trichloroethylene, perchloroethylene, methylene chloride, or ethanol) for 3 months, followed by an exposure-free rehabilitation period of 4 months, to determine whether any irreversible cellular changes had occurred in the brain. Increases in brain protein levels, which are known to indicate cell proliferation characteristic of irreversible brain damage (Persson et al. 1976; Bignami and Dahl 1974), were shown following inhalation of 60 parts per million (ppm) of trichloroethylene, 60 ppm of perchloroethylene, or 350 ppm of methylene chloride, or following daily ethanol ingestion of 11.7 grams per kilogram (g/kg) of body weight. The investigators concluded that these changes may indicate irreversible brain reactions to organic solvent exposure.
Human Health Effects
Acute Toxicity
The acute, transient neurotoxic effects of organic solvent exposure in humans result from the pharmacologic action of the solvent within the CNS. These effects include CNS depression, psychomotor impairment, and narcosis. Solvent inhalation by workers may cause effects ranging from an alcohol-like intoxication to narcosis and death from respiratory failure, with a spectrum of intermediate symptoms that include drowsiness, headache, dizziness, dyspepsia, and nausea (Browning 1965).
In several Swedish and Finnish investigations, acute experimental exposure of human subjects to methyl chloroform (1,1,1-trichloroethane), styrene, or toluene impaired psychomotor functions of the CNS as measured by performance of a task. Inhalation exposure to these organic solvents for up to 2 hr at or above the NIOSH REL's of 350 ppm (ceiling) (NIOSH 1976b), 50 ppm (TWA) (NIOSH 1983a), or 100 ppm (TWA) (NIOSH 1973a), respectively, impaired simple or choice reaction time, perceptual and sensory motor speed, or manual dexterity and coordination in a statistically significant manner (p<0 .05="" a="" href="http://www.cdc.gov/niosh/docs/87-104/default.html" style="color: #4a006e; margin: 0px; padding: 0px;">Gamberale and Hultengren 1972
The effects of exposure on mood change were measured using visual analogue scales in 108 factory workers exposed to solvents (styrene, 6 to 191 ppm; methylene chloride, 28 to 173 ppm; or trichloroethane, toluene, and xylene combined, 3 to 67 ppm) during the production of fibrous glass panels and boats, acetate film, or paint (Cherry et al. 1983). The workers' subjective ratings of mood indicated a statistically significant deterioration (p<0 .05="" a="" and="" at="" between="" blood="" by="" chloride="" compared="" control="" controls="" correlation="" deterioration="" during="" elevation="" end="" evaluated="" existed="" exposed="" for="" general="" good="" health="" in="" level="" levels="" low="" measured="" mental="" methylene="" mood="" of="" or="" p="" physical="" ratings="" result="" significant="" sleepiness="" solvent="" statistically="" styrene.="" styrene="" the="" this="" tiredness="" to="" unexposed="" was="" were="" when="" with="" workers="" workshift.="" workshift="">
). The painters demonstrated statistically significant decreases (p<0 .05="" and="" compared="" conduction="" electronics="" groups="" in="" matched="" motor="" nerve="" of="" p="" plant="" reference="" sensory="" unexposed="" velocities="" when="" with="" workers.="">Chronic Toxicity
Two international workshops have categorized solvent-induced CNS disorders according to their severity (Table 1) (WHO 1985; Baker et al. 1986). Correspondence between the two systems of nomenclature is not exact, but the categories produced by these two workshops do help clarify the chronic effects of solvents on the CNS. The further development of a standardized approach to describing the effects of chronic solvent exposure on the CNS will aid in the interpretation of studies in different parts of the world (Waldron 1986).
Each workshop identified three categories of effect, varying from minimal and reversible to pronounced and irreversible. Using the nomenclature from either workshop will be useful in classifying effects in future epidemiologic and clinical studies.
The mildest type of disorder is the organic affective syndrome (WHO Workshop), or the Type 1 disorder (International Solvent Workshop). This disorder is characterized by fatigue, memory impairment, irritability, difficulty in concentrating, and mild mood disturbance.
Table 1. Categories of solvent-induced CNS disorders*
| Category of CNS disorder | ||
| Severity of condition | Identified by WHO/Nordic Council of Ministers Working Group, Copenhagen, June 1985** | International Solvent Workshop, Raleigh, N.C. October 1985*** |
|---|---|---|
| Minimal | Organic Affective syndrome | Type 1 |
| Moderate | Mild chronic toxic encephalopathy | Types 2A or 2B |
| Pronounced | Severe chronic toxic encephalopathy | Type 3 |
* In view of the difficulty of categorizing these disorders, correspondence between the two systems of nomenclature is not exact. [return to table]
** WHO 1985. [return to table]
*** Baker and Seppalainen 1986. [return to table]
** WHO 1985. [return to table]
*** Baker and Seppalainen 1986. [return to table]
The second level of disorder is described as mild chronic toxic encephalopathy (WHO Workshop), or the Type 2 disorder (International Solvent Workshop). This level involves both symptoms of neurotoxicity and abnormalities of performance on formal neuropsychological testing. The Type 2 disorder has been divided into Type 2A (sustained personality or mood changes such as emotional instability and diminished impulse control and motivation) and Type 2B (impairment in intellectual function manifested by diminished concentration, memory, and learning capacity).
The third and most pronounced level of disorder is described as severe chronic toxic encephalopathy (WHO Workshop), or the Type 3 disorder (International Solvent Workshop). The condition is characterized by global deterioration in intellectual and memory functions (dementia) that may be irreversible, or at best, only poorly reversible.
Type 1 and 2 disorders are the most likely to be reported among solvent-exposed workers. Type 3 disorders to date have been seen only in individuals who have abused solvent-containing products (i.e., by deliberately inhaling organic solvent vapors for their euphoric properties). For example, persons who abusively inhaled toluene almost daily for 1 to 7 years showed evidence of severe, multifocal CNS damage with cortical, cerebellar, and brain stem atrophy, electrophysiologic abnormalities, and neuropsychologic deficits (Lazar et al. 1983).
Neurophysiologic Effects
Neurophysiologic methods are useful indicators of nervous system malfunction or damage (Seppalainen 1985). Studies of various groups of solvent-exposed workers have demonstrated changes in neurophysiologic parameters measured by electroencephalograms (EEG's) and tests of peripheral nerve function.
Neurophysiologic effects of chronic exposure to a mixture of organic solvents were studied in 102 Finnish automobile spray painters who had a mean employment time of 14.8 years in car repair garages (Seppalainen et al. 1978). These painters were exposed to mixtures of nine organic solvents, the main components of which were butyl acetate, toluene, white mineral spirits, and xylene. Mean breathing zone concentrations for these four solvents were below the Finnish threshold limit values (150, 200, 200, and 100 ppm, respectively) and below the NIOSH REL's (none, 100, 55, and 100 ppm, respectively) (NIOSH 1973a, 1975, 1977c)--or in the absence of a REL, below the OSHA PEL (butyl acetate, 150 ppm) (29 CFR 1910.1000). A statistically significant decrease (p<0 .05="" 19="" a="" absence="" age-matched="" an="" and="" at="" automobile="" below="" breathing="" chronic="" compared="" concentrations="" conduction="" eighty="" engineers.="" experienced="" exposure="" exposures="" group="" href="http://www.cdc.gov/niosh/docs/87-104/default.html" in="" industrial="" limit="" mixtures="" most="" motor="" nerve="" niosh="" noted="" occupational="" of="" organic="" osha="" painters="" pel="" railroad="" reference="" rel="" s--or="" sensory="" solvents="" spray="" style="color: #4a006e; margin: 0px; padding: 0px;" swedish="" the="" to="" values="" velocities="" was="" with="" zone="">Elofsson et al. 1980
Seventy-seven workers were diagnosed as having "solvent poisoning" caused by occupational exposure (mean of 9.6 years for males and 7.6 years for females) to organic solvents such as halogenated, aromatic, and aliphatic hydrocarbons, paint solvents, and alcohol. The potential exposure of each subject was graded as low, intermediate, or high, based on workplace measurements of the solvents and information provided by the subject or the employer (Seppalainen et al. 1980). The frequency of abnormally slow nerve conduction velocities increased in a statistically significant manner (p<0 .05="" compared="" exposure="" group.="" group="" high="" intermediate="" p="" the="" was="" when="" with="">
). A study of automobile and industrial spray painters revealed no statistically significant differences between exposed and reference populations in the visual evaluation of EEG'S, but it described subtle EEG abnormalities (increased alpha activity) in the exposed group (Elofsson et al. 1980). A cross-sectional study of the effects of chronic exposure (mean of 18 years) to solvents in the paint industry showed statistically significant differences (p<0 .05="" a="" activity="" compared="" eeg="" exposed="" group="" href="http://www.cdc.gov/niosh/docs/87-104/default.html" in="" of="" style="color: #4a006e; margin: 0px; padding: 0px;" the="" unexposed="" when="" with="" workers="">Orbaek et al. 1985). The EEG results suggest changes in neurologic function indicative of chronic organic solvent exposure. EEG abnormalities persisted for 3 to 9 years in 42% of a group of patients diagnosed as having chronic solvent intoxication after occupational exposure (Seppalainen and Antti-Poika 1983).
A followup study was conducted with 87 patients 3 to 9 years after they were diagnosed as having chronic solvent intoxication following occupational exposure (mean of 10.7 years) to trichloroethylene, perchloroethylene, or solvent mixtures. The frequency of slow nerve conduction velocities in these workers remained relatively similar, and electromyographic abnormalities (fibrillations and loss of motor units) increased. These results suggest that electrophysiologic abnormalities may be permanent even after workers are removed from organic solvent exposure (Seppalainen and Antti-Poika 1983).
Studies of groups of solvent-exposed workers have also shown statistically significant differences in EEG abnormalities when compared with unexposed populations. One study involved 30 workers who were exposed for a mean of 17 years to jet fuel composed of organic hydrocarbons. The workers showed statistically significant (p<0 .05="" a="" activity="" alpha="" amplitude="" compared="" controls="" differences="" eeg="" frequencies="" higher="" href="http://www.cdc.gov/niosh/docs/87-104/default.html" less="" lower="" matched="" observable="" peak="" rhythmic="" style="color: #4a006e; margin: 0px; padding: 0px;" unexposed="" when="" with="">Knave et al. 1978
Neurobehavioral Effects
When compared with groups of unexposed workers, groups exposed to solvents showed increases in subjective symptoms (Type 1), personality and mood changes (Type 2A), and poor performance on tests of CNS function, which indicated intellectual impairment (Type 2B). Studies were conducted of automobile and industrial spray painters with long-term exposures to organic solvents at concentrations below the Swedish occupational exposure limit values and most NIOSH REL's--or in the absence of REL's, OSHA PEL's. These workers exhibited a statistically significant incidence (p<0 .001="" 1="" a="" compared="" complaints="" e.g.="" fatigability="" groups="" headache="" href="http://www.cdc.gov/niosh/docs/87-104/default.html" matched="" memory="" of="" problems="" psychiatric="" reference="" style="color: #4a006e; margin: 0px; padding: 0px;" subjective="" type="" unexposed="" when="" with="">Elofsson et al. 1980
). Psychologic testing also revealed statistically significant differences (p<0 .05="" and="" between="" dexterity="" exposed="" groups="" in="" manual="" memory.="" p="" perceptual="" reaction="" reference="" short-term="" simple="" speed="" the="" time="">
Neurobehavioral performance tests of CNS function (i.e., Block Design and Embedded Figures) were administered to 55 shipyard painters, 95% of whom had more than 10 years of work experience that involved exposure to methyl isobutyl ketone, perchloroethylene, xylene, ethylene glycol, and mineral spirits. The test scores of the exposed workers were significantly lower (p<0 .004="" a="" control="" href="http://www.cdc.gov/niosh/docs/87-104/default.html" of="" style="color: #4a006e; margin: 0px; padding: 0px;" than="" the="" those="" unexposed="" workers="">Valciukas et al. 1985
).
Neurologic and psychologic tests were administered to 65 workers (housepainters, paint and varnish factory workers, printers, dry cleaners, and boat factory workers) exposed primarily to white mineral spirits, toluene, perchloroethylene, or styrene for a mean of 12.9 years (Gregersen et al. 1984). Compared with an unexposed reference population, the exposed workers exhibited more symptoms of personality and mood change (Type 2A) and a statistically significant increase (p<0.05) in unspecified emotional changes. The exposed workers also showed a statistically significant decrease (p<0.05) in performance on the neuropsychologic tests of concentration ability/attention and abstraction functions (Type 2B) and a statistically significant correlation (p=0.045) between degree of exposure and neuropsychologic and neurologic test performance. In addition, the exposed workers had lower scores in all five tests for learning/memory and in the combined index for intellectual impairment, although none of these were statistically significant. Also noted was a statistically significant frequency (0.01<<0.55) of cerebral asthenopia (tiring, pain, and weakness in the eyes) among the exposed workers. This condition has been reported in another study in connection with diffuse cerebral atrophy (Willanger and Klee 1966).
Fifty workers exposed to solvents in the paint industry for a mean of 18 years, and 50 unexposed matched controls received psychiatric and psychologic examinations (Orbaek et al. 1985). Results of the psychiatric examinations showed that the exposed workers had a statistically significant increase (p<0 .05="" 10="" 14="" 15="" a="" abilities--was="" an="" analyzed="" and="" as="" attention="" battery="" brain="" but="" by="" compared="" consisted="" correlated="" definite="" deviation="" different="" disturbance.="" disturbance="" dysfunction="" e.g.="" each="" encephalopathy.="" encephalopathy="" examination="" examining="" exhibited="" exposed="" exposure="" fatigability="" feelings="" focused="" for="" frequent="" greater="" group="" had="" hostile="" in="" index="" indicated="" indications="" individual="" lower="" manner="" measure="" memory="" mental="" more="" none="" of="" one="" only="" organic="" p="" performance="" problems="" profiles="" psychologic="" psychometric="" received="" reference="" result="" revealed="" scores="" significant="" significantly="" solvents="" statistically="" subject="" subjects="" suggests="" sum="" suspected="" symptoms="" tension="" test="" tests="" than="" that="" the="" this="" to="" toxic="" unexposed="" variable--a="" variables="" with="" workers.="" workers="">l standard deviation) from expected values in two or more of the psychometric variables tested. The exposed workers with indications of brain dysfunction were among the more heavily exposed subjects, indicating a possible relationship between exposure level and effect.
Evaluations of neurobehavioral functions in groups of workers exposed to solvents have also addressed the reversibility of CNS effects resulting from solvent exposure. Fifty-six workers were diagnosed as having occupational diseases caused by exposure to organic solvents (primarily halogenated and aromatic hydrocarbons and mixtures of paint solvents) for a mean duration of 9.1 years at concentrations reported to be generally below the Finnish threshold limit value (Lindstrom 1980). The workers were given a series of psychologic tests 5 or more years after cessation of solvent exposure. Test results revealed a statistically significant decrement (p<0 .05="" a="" and="" compared="" control="" declined="" distractibility="" duration="" exposure="" freedom="" from="" groups.="" href="http://www.cdc.gov/niosh/docs/87-104/default.html" in="" increasing="" manner="" nbsp="" of="" p="" performance="" significant="" solvent="" statistically="" style="color: #4a006e; margin: 0px; padding: 0px;" styrene-exposed="" those="" unexposed="" visuomotor="" when="" with="">Bruhn et al. 1981
found that neurologic status and degree of neuropsychologic impairment were unchanged in 26 former house painters who had been diagnosed 2 years previously as having chronic toxic encephalopathy (cerebral atrophy and/or intellectual impairment) following a mean solvent exposure of 28 years.Metabolism
Absorption
Inhalation and percutaneous absorption are the primary routes of solvent uptake into the peripheral blood, which begins within minutes of the onset of exposure (WHO 1985; Engstrom et al. 1978). Uptake by inhalation is the principal route and depends on the following: solvent concentration in inhaled air blood/air partition coefficient of the solvent (which is determined by alveolocapillary membrane permeability and blood solubility), alveolar ventilation rate, blood perfusion of the lungs, and duration of exposure (WHO 1985; Astrand 1975). Increased levels of physical exercise increase pulmonary ventilation and cardiac output and lead to increased pulmonary solvent uptake over baseline resting levels in volunteers. A 27% increase in solvent uptake was noted in an inhalation study using 1,1,1-tri-chloroethane (Monster et al. 1979), and a 28% increase was reported in a study using xylene (Riihimaki et al. 1979). Percutaneous absorption is also a major route of entry for organic solvents that are readily soluble in both lipids and water. Immersion of both hands in xylene for 15 min produced blood concentrations of xylene roughly the same as those following inhalation of 100 ppm for an equal period of time (Engstrom et al. 1977). Solvent uptake through the skin depends on (1) duration of contact, (2) skin thickness, perfusion, and degree of hydration, and (3) the presence of cuts, abrasions, or skin diseases (Riihimaki and Pfaffli 1978; Bird 1981).
Distribution and Transformation
Following absorption, organic solvents undergo biotransformation (which occurs primarily in the liver), or they accumulate in lipid-rich tissues such as those of the nervous system (WHO 1985;Bergman 1983). Metabolism in the liver generally consists of oxidative reactions catalyzed by the cytochrome P-450 mixed-function oxidase system followed by conjugation with glucuronic acid, sulfuric acid, glutathione, or glycine. Metabolism usually results in the detoxication of the organic solvent through formation of water-soluble compounds that are excreted through urine or bile (Toftgard and Gustafsson 1980). However, metabolism may also produce reactive intermediate metabolites that are more toxic than the parent compound.
These metabolites are capable of covalently binding to essential macromolecules (e.g., proteins, RNA, and DNA) and producing toxic effects (Toftgard and Gustafsson 1980; WHO 1985). For example, n-hexane and methyl n-butyl ketone (solvents that produce peripheral neuropathies in exposed workers [Herskowitz et al. 1971; Spencer et al. 1980b]) are both metabolized to 2,5-hexanedione (DiVincenzo et al. 1980), which has been shown to have a greater neurotoxic potency than either parent compound (Krasavage et al. 1980). This type of metabolic activation of solvents is believed to be mediated by the cytochrome P-448 system, which is more predominant in extrahepatic tissues (WHO 1985).
Studies have been conducted on the modification of solvent metabolism rates in exposed workers by other exogenous substances, principally ethanol. The combined inhalation of toluene and ingestion of ethanol by seven volunteers caused a statistically significant increase (p<0 .05="" a="" alcohol="" blood="" compared="" concentrations="" exposure="" href="http://www.cdc.gov/niosh/docs/87-104/default.html" in="" no="" style="color: #4a006e; margin: 0px; padding: 0px;" toluene="" when="" with="">Waldron et al. 1983
). The authors concluded that this increase in blood toluene concentration is possibly, a result of competition for alcohol dehydrogenase necessary for the metabolism of both toluene and ethanol. In contrast, 33 toluene-exposed workers who chronically ingested alcohol had significantly lower blood toluene concentrations (p<0 .05="" 13="" a="" alcohol-mediated="" an="" as="" did="" drank.="" enzymes="" factory="" from="" hepatic="" href="http://www.cdc.gov/niosh/docs/87-104/default.html" in="" increase="" induction="" metabolism="" metabolizing="" microsomal="" of="" result="" same="" seldom="" solvent-="" style="color: #4a006e; margin: 0px; padding: 0px;" suggests="" than="" the="" this="" toluene="" who="" workers="">Waldron et al. 1983). In a study of the metabolic, interaction of ethanol and xylene, 14 volunteers were exposed to m-xylene in an inhalation chamber, with and without prior ethanol ingestion (Riihimaki et al. 1982). The preexposure ingestion of ethanol caused statistically significant increases (p<0 .05="" acute="" an="" and="" appears="" blood="" by="" chronic="" compared="" competition="" concentrations.="" concentrations="" corresponding="" enzymes="" ethanol-mediated="" ethanol.="" ethanol="" exposures="" for="" in="" induces="" ingestion="" inhibition="" interactions.="" it="" lowers="" may="" metabolic="" metabolism.="" metabolism="" microsomal="" mixtures="" of="" or="" p="" produced="" raises="" result="" several="" similar="" simultaneously="" solvent-metabolizing="" solvent="" solvents="" suggests="" that="" thereby="" this="" those="" through="" thus="" to="" toluene="" whereas="" with="" without="" workplace="" xylene="">Excretion
Solvent elimination occurs through exhalation of the parent compound in expired air or through urinary or biliary excretion of water-soluble metabolites or of unchanged solvent. Because excretion kinetics vary among compounds kinetics must be considered in planning biologic monitoring in which elimination of these compounds is measured as an estimate of solvent uptake (Baker et al. 1985).
Conclusions
The research data presented in this CIB have focused on the neurotoxic effects produced in humans and animals exposed to organic solvents on an acute or chronic basis. The acute effects of solvent inhalation in both humans and animals include narcosis, anesthesia, CNS depression, respiratory arrest, unconsciousness, and death. The majority of organic solvents have yet to be tested for chronic neurotoxic effects in animals; thus experimental animal data supporting the evidence for chronic effects confirm only a limited number of organic solvents as neurotoxicants (see Appendix B). Research indicates that chronic exposure of animals to some organic solvents may cause irreversible CNS changes that are characteristic of brain damage.
In man, the acute reversible effects of exposure to organic solvents appear to result from properties of the parent compound. However, the chronic effects may be caused by metabolic activation of the parent compound, which results in more reactive intermediate metabolites (e.g., 2,5-hexanedione, a metabolite of n-hexane and methyl n-butyl ketone) that may alter nervous tissue structure. Chronic effects are often correlated with changes in nervous tissue structure and function that may be irreversible.
Chronic neurotoxicity in workers exposed to organic solvents over a period of months to years includes (1) peripheral neuropathies such as axonal degeneration seen in workers exposed to hexacarbon solvents (e.g., n-hexane, methyl n-butyl ketone), (2) Type 1 CNS symptoms such as fatigability irritability, and memory impairment, and (3) Type 2 mild toxic encephalopathy, including sustained personality or mood changes such as emotional instability, diminished impulse control and motivation, and impairment in intellectual function manifested by diminished concentration, memory, and learning capacity. Epidemiologic studies have demonstrated correlations of workplace solvent exposures with the types of solvent-related CNS dysfunctions noted above and changes in neurophysiologic parameters such as nerve conduction velocities. Studies have demonstrated that these effects can persist for months to years after removal of workers from solvent exposure. The extent to which chronic neurotoxicity is reversible remains to be established; peripheral nerves have the capacity to regenerate, but damage to the CNS is more often permanent.
The nervous system effects of exposure to organic solvents can lead to significant morbidity and increased risk of accidental injury, both on the job and away from work. The precise extent to which worker exposure to organic solvents increases the likelihood of accidents or illnesses remains to be determined, however.
The studies that indicate the potential for organic solvents to induce toxic effects on the human nervous system are not without shortcomings. Some evidence of CNS impairment is based on subjective data gathered from questionnaires. Neurophysiologic and neuropsychologic methods of detecting nervous system damage or deviations from normal CNS function can be questioned in epidemiologic studies because of the variability of response in normal individuals. In addition, workers using solvents are often exposed to complex mixtures of organic chemicals and other workplace chemical hazards; such exposures can confound the interpretation of epidemiologic data. However, NIOSH believes that the collective toxicologic and epidemiologic data on organic solvent neurotoxicity provide sufficient evidence to warrant concern about adverse health effects from occupational exposure to these chemicals.
Research Needs
The following research needs have been identified:
- Testing of chemical classes and structural analogues to provide the ability to predict neurotoxicity,
- Establishment of an adequate animal model to predict chronic neurobehavioral toxicity,
- Determination of the pathways and metabolic rates of specific solvents by brain and nerve tissues and the ability of these solvents to bind and accumulate in the CNS,
- Correlation of reported neurotoxic effects with exposure data,
- Epidemiologic research to establish the prevalence and incidence of neurologic disorders and to identify and validate quantitative tests for screening workers,
- Determination of the reversibility of neurotoxic effects of solvent exposure,
- Identification of the interactions or synergistic effects of solvent mixtures found in the workplace and the role of alcohol and other drugs in these interactions,
- Determination of the extent to which solvent exposure may increase accidental injuries on the job and away from work,
- Evaluation of the role of medical monitoring in the protection of workers exposed to neurotoxic solvents,
- Development of improved methods for primary prevention of worker exposure (i.e., engineering controls, personal protective equipment, and work practices), and
- Development of new methods for biologic or process monitoring of skin exposures to organic solvents.
Recommendations
Occupational exposure to organic solvents can cause adverse health effects, and the potential for these solvent-induced effects may increase the risk of accidental injuries. NIOSH therefore recommends that engineering controls and personal protective equipment and clothing be used to reduce solvent exposures--at least to concentrations specified in existing OSHA PEL's, or to NIOSH REL's or ACGIH TLVs if they provide greater protection. NIOSH considers the PEL's, REL's, and TLVs for the specific organic solvents found in the workplace to be upper boundaries of exposure. Employers should therefore make every effort to keep exposure concentrations below these levels. Worker education programs should be instituted to inform workers about the hazards of exposure to organic solvents and to provide information on safe handling practices.
Many organic solvents are recognized by NIOSH as carcinogens or as reproductive hazards in the workplace. Examples of carcinogens recognized by NIOSH are benzene (NIOSH 1976c), carbon tetrachloride (NIOSH 1976d), trichloroethylene (NIOSH 1978d), and 1,1,2,2-tetrachloroethane (NIOSH 1978b). Reproductive hazards recognized by NIOSH include 2-methoxyethanol and 2-ethoxyethanol (NIOSH 1983a), and methyl chloride (NIOSH 1984a). NIOSH is also concerned about those organic solvents for which only neurotoxic effects have been reported. No precise determination has been made about the excess risk (i.e., risk beyond that expected in an unexposed population) of neurotoxic effects in workers exposed to organic solvents but the probability that a worker will exhibit such effects would be decreased by reducing exposure. Prudent public health policy requires that employers voluntarily assess the conditions under which workers may be exposed to organic solvents and take all reasonable precautions to reduce exposure.
Guidelines for Minimizing Worker Exposure to Organic Solvents
The guidelines below are general in nature and should be adapted to specific work situations as required. The area in which organic solvents are used should be restricted to those workers essential to the process or operation.
Exposure Monitoring
Qualified industrial hygiene personnel should make initial and periodic surveys of worker exposure. These surveys are necessary to determine the extent of worker exposure and to ensure that controls already in place are operational and effective. The NIOSH Occupational Exposure Sampling Strategy Manual (Leidel et al. 1977) may be helpful in developing efficient programs to monitor worker exposure to organic solvents. The manual discusses how to determine the need for exposure measurements and how to select sampling times.
Worker exposures to airborne contaminants should be estimated by 8-hr (or other full-shift) time-weighted averages (TWA's) and short-term (15-min) exposures calculated from personal (breathing zone) samples. Short-term samples should be taken during periods of maximum expected exposure by using all available knowledge of the work areas, procedures, and processes. Area and personal measurements may be useful in identifying sources of exposure at processes and operations.
Detailed analytical methods for individual organic solvents are in the NIOSH Manual of Analytical Methods, second and third editions (NIOSH 1978c, 1984b).
Controlling Worker Exposure
Proper maintenance procedures and worker education are all vital aspects of a good control program. An education program should be used to inform workers about the materials to which they are exposed, the nature of the hazards they pose, the methods for control, and appropriate personal hygiene procedures (29 CFR 1910.1200). Workers should also be given access to relevant exposure and medical records (29 CFR 1910.20). Three basic methods exist for limiting worker exposures to organic solvents: the use of contaminant controls, worker isolation, and personal protective equipment. Careful planning and thought should precede implementation of these methods.
Contaminant Controls
Engineering controls should be used as the primary method to eliminate the potential for organic solvent exposure in the workplace and to prevent fires and explosions. Achieving and maintaining reduced concentrations of organic solvents in the workplace depend on the implementation of engineering control measures such as properly constructed and maintained closed-system operations and exhaust ventilation with appropriate safety designs.
Closed-system operations provide the most effective means for minimizing worker exposures to organic solvents. Closed-system equipment should be used for manufacturing, storing, and processing organic solvents. Where closed systems cannot be used, local exhaust ventilation should be provided to direct vapors away from workers and to prevent the recirculation of contaminated exhaust air. Exhaust ventilation systems for quality control laboratories or laboratories where samples are prepared for analyses should be designed for adequate capture and containment of organic solvent vapors. Special consideration should be given to exposures that may occur during the release of these compounds from pressurized sampling containers. Guidance for designing local exhaust ventilation systems can be found in Recommended Industrial Ventilation Guidelines(Hagopian and Bastress 1976), Industrial Ventilation--A Manual of Recommended Practice (ACGIH 1984), and Fundamentals Governing the Design and Operation of Local Exhaust Systems, ANSI Z9.2-1979 (ANSI 1979).
Ventilation equipment should be checked at intervals that will ensure adequate performance. System effectiveness should also be checked when there are any changes in production, process, or control that might result in increased exposure to airborne organic solvents.
Worker Isolation
If feasible, workers should be isolated from direct contact with the work environment by the use of automated equipment operated from a closed control booth or room. The control room should be maintained at a greater air pressure than that surrounding the process equipment so that air flows out of the room rather than into it. Note, however, that this type of control will not protect workers who must perform process checks, adjustments, maintenance, and related operations. Thus special precautions are often necessary to prevent or limit worker exposure in these situations, and they frequently involve the use of personal protective equipment.
Personal Protective Equipment
Direct skin contact with organic solvents should be prevented through the proper use of solvent-resistant gloves, aprons, boots, or entire work suits, depending on the nature and extent of the hazard. Face shields or chemical safety goggles should be used wherever the potential for splashing exists. Any clothing that becomes contaminated with organic solvents should be removed and discarded or cleaned before reuse. Areas of the body that come in contact with organic solvents should be thoroughly washed with soap and water. As a general hygienic measure, facilities (e.g., change rooms, showers, etc.) should be provided for personal cleanliness.
The use of respiratory protection is the least preferred method of controlling exposures to airborne contaminants and should not be used as the only means of preventing or minimizing airborne exposures during routine operations. However, NIOSH recognizes that respirators may be required for protection in certain situations such as implementation of engineering controls, some short-duration maintenance procedures, and emergencies.
The use of respiratory protection requires employers to institute a respiratory protection program that, at a minimum, meets the requirements of 29 CFR 1910.134. A complete respiratory protection program should include (1) selection of respirators approved by the Mine Safety and Health Administration (MSHA) and NIOSH, (2) regular training of personnel, (3) fit testing, (4) periodic environmental monitoring, and (5) maintenance, inspection, and cleaning of equipment. The program should be evaluated regularly.
Selection of the proper respirator depends on the contaminant concentration, fit testing results, and specific conditions of use. Types of respirators recommended for protection against organic solvents are presented in Tables 2 through 4. Table 2 lists the types of respirators recommended for protection against solvents identified by NIOSH as potential occupational carcinogens. Table 3 lists types of respirators recommended for protection against organic solvents with poor warning characteristics or organic solvents for which effective adsorption-filtering media are unavailable.
Table 4 lists both air-purifying and atmosphere-supplying respirators recommended for chemicals with good warning properties.
Selection of a specific respirator should be based on the required reduction in solvent concentration, special use conditions, and the worker's proven ability (through fit testing) to wear the respirator. Note that air-purifying cartridge respirators cannot be used for solvent concentrations exceeding 1,000 ppm and that full facepieces, helmets, or hoods are recommended when eye irritation occurs.
Table 2. Respirator Selection Table for Solvents Identified by NIOSH as Potential Carcinogens
| Condition of Use | Type of Respirator Recommended |
|---|---|
| Any detectable concentration | Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode |
| Any supplied-air respirator that has a full facepiece and is operated in pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained breathing apparatus operated in pressure-demand or other positive-pressure mode | |
| Escape only | Any full-facepiece respirator (gas mask) with a suitable organic vapor canister, or any appropriate self-contained breathing apparatus of the escape-type |
Table 3. Respirator Selection Table for Noncarcinogenic Solvents with Poor Warning Properties or Without Suitable Adsorption Filtering Media
| Condition of Use | Type of Respirator Recommended |
|---|---|
| Contaminant reduction multiple (protection factor) of: | |
| 10x | Any self-contained breathing apparatus* |
| Any supplied-air respirator* | |
| 25x | Any supplied-air respirator operated in a continuous-flow mode* |
| 50x | Any supplied-air respirator with a full facepiece |
| Any self-contained breathing apparatus with a full facepiece | |
| Any supplied-air respirator that has a tight-fitting facepiece and is operated in a continuous-flow mode | |
| 1,000x | Any supplied-air respirator that has a half facepiece and is operated in pressure-demand or other positive-pressure mode* |
| 2,000x | Any supplied-air respirator that has a full facepiece and is operated in pressure-demand or other positive-pressure mode |
| A contaminant concentration that is IDLH** or unknown, or a contaminant reduction multiple greater than 2,000x | Any self-contained breathing apparatus that has a fullpiece and is operated in pressure-demand or other positive-pressure mode |
| Any supplied-air respirator that has a full facepiece and is operated in pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained breathing apparatus operated in pressure-demand or other positive-pressure mode | |
| Escape only | Any full-facepiece respirator (gas mask) with an appropriate organic vapor canister or appropriate self-contained breathing apparatus of the escape-type |
* If eye irritation occurs, use full facepiece or other eye protection. [return to table]
** Immediately dangerous to life or health. This level represents a maximum concentration from which one could escape within 30 min without any escape-impairing symptoms or any irreversible health effects. [return to table]
** Immediately dangerous to life or health. This level represents a maximum concentration from which one could escape within 30 min without any escape-impairing symptoms or any irreversible health effects. [return to table]
Table 4. Respirator Selection Table for Noncarcinogenic Solvents with Good Odor Warning Properties and Suitable Adsorption Filtering Media
| Condition of use | Type of respirator recommended |
|---|---|
| Contaminant reduction multiple (protection factor) of: | |
| 10x | Any chemical cartridge, half-facepiece respirator*, † |
| Any self-contained breathing apparatus* | |
| Any supplied-air respirator* | |
| 25x | Any supplied-air respirator operated in a continuous-flow mode* |
| Any powered air-purifying respirator with suitable organic vapor cartridge(s)† | |
| 50x | Any full-facepiece respirator with suitable organic vapor cartridge(s)† |
| Any full-facepiece respirator (gas mask) with a suitable organic vapor canister† | |
| Any supplied-air respirator with a full facepiece | |
| Any self-contained breathing apparatus with a full facepiece | |
| Any powered air-purifying respirator with a tight-fitting facepiece and appropriate organic vapor cartridge(s)*, † | |
| Any supplied-air respirator with a tight-fitting facepiece and continuous-flow mode operation | |
| 1,000x | Any supplied-air respirator that has a half facepiece and is operated in pressure-demand or other positive-pressure mode* |
| 2,000x | Any supplied-air respirator that has a full facepiece and is operated in pressure-demand or other positive-pressure mode |
| A contaminant concentration that is IDLH§ or unknown, or a contaminant reduction multiple greater than 2,000x | Any self-contained breathing apparatus with a full facepiece operated in a pressure-demand or other positive presure mode |
| Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained breathing apparatus operated in pressure-demand or other positive-pressure mode | |
| Escape only | Any full-facepiece respirator (gas mask) with an appropriate organic vapor canister or appropriate self-contained breathing apparatus of the escape-type |
* If eye irritation occurs, use a full-facepiece respirator or other eye protection.[return to table]
†-purifying cartridge respirators cannot be used for concentrations exceeding 1,000 ppm. [return to table]
§Immediately dangerous to life or health. This level represents a maximum concentration from which one could escape within 30 min without any escape-impairing symptoms or any irreversible health effects. [return to table]
†-purifying cartridge respirators cannot be used for concentrations exceeding 1,000 ppm. [return to table]
§Immediately dangerous to life or health. This level represents a maximum concentration from which one could escape within 30 min without any escape-impairing symptoms or any irreversible health effects. [return to table]
Worker Education
Employers are to establish a worker education program for all workers exposed to hazardous chemicals. Training is to be provided at the time of initial assignment and whenever a new chemical hazard is introduced into the work area. This training should be designed to inform the worker about the materials to which they are exposed, the potential health risks from exposure to these materials, the proper use of personal protective equipment and clothing and other methods for control, and proper work practice procedures (29 CFR 1910.1200).
Medical Surveillance
Employers should establish a medical surveillance program to evaluate both the acute and chronic effects of exposure to organic solvents. The physician should be given information concerning the adverse effects of exposure to organic solvents and an estimate of the worker's potential exposure to them. This information should include any available results from workplace sampling and a description of any protective devices or equipment the worker may be required to use. A medical and work history should be taken initially and updated periodically. Workers who are currently exposed or who may be exposed to organic solvents should have preplacement and periodic evaluations focusing on their histories of previous exposure to organic solvents and other agents, particularly those associated with neurotoxic effects. The examining physician should direct particular attention to the nervous, respiratory, reproductive, and cardiovascular systems, and to the skin, eyes, liver, blood, kidneys, and gastrointestinal tract, as these are the most likely targets for the adverse effects of organic solvents.
Source: http://www.cdc.gov/
No comments:
Post a Comment